Pazoo, Inc. is a health and wellness company. The Company is engaged in providing infrastructure and analytical services to legally authorized distributors and producers of organic medicines and to regulators tracking their operations. Its line of business relating to and revolving around the cannabis industry. It holds an interest in MA & Associates LLC, a testing lab providing laboratory testing of cannabis.

Employees

Sector

Healthcare Facilities & Services

More about the company

Quotes

Date	Price	Change	Volume

Delayed Quote OTC Markets

More quotes

Market Closed - OTC Markets 09:30:05 2026-08-24 EDT			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-

22-10-27	Mark Sarna entered into a Letter of Intent to acquire a 20% stake in MA & Associates, LLC from Pazoo, Inc. for $0.995747 million.	CI
20-09-09	An unknown buyer acquired an additional 10% stake in MA & Associates, LLC from Pazoo, Inc. for $0.23 million.	CI

Market Cap	1.07M 929K 879K 799K 1.49M 102M 1.5M 10.47M 4.05M 51.93M 4.01M 3.92M 166M	P/E 2016	-0.01x	P/E 2017	-0.03x
Enterprise Value	4.11M 3.58M 3.39M 3.08M 5.76M 394M 5.78M 40.39M 15.62M 200M 15.45M 15.11M 641M	EV / Sales 2016	127x	EV / Sales 2017	-
Free-Float	99.91%	Yield 2016 *	-	Yield 2017	-

22-10-27	Mark Sarna entered into a Letter of Intent to acquire a 20% stake in MA & Associates, LLC from Pazoo, Inc. for $0.995747 million.	CI
20-09-09	An unknown buyer acquired an additional 10% stake in MA & Associates, LLC from Pazoo, Inc. for $0.23 million.	CI
17-12-30	An undisclosed buyer completed the acquisition of 70% membership interests in MA & Associates LLC from Pazoo, Inc. (OTCPK : PZOO).	CI
17-11-29	An undisclosed buyer entered into an agreement to acquire 70% membership interests in MA & Associates LLC from Pazoo, Inc. (OTCPK : PZOO) for $1.5 million.	CI
17-09-15	Pazoo, Inc. Announces Executive Changes	CI
17-04-03	Pazoo, Inc. cancelled the transaction announced on April 4, 2014	CI
16-07-14	Pazoo, Inc Implements New Validating of Testing	CI
16-06-18	Industrial Hemp and Medical Marijuana Consulting Company Signs Agreement with Pazoo	CI
16-04-26	Pazoo, Inc. will Change its Ticker to PZOO from PZOOD	CI
16-03-30	Pazoo, Inc. will Change its Ticker to PZOO from PZOO.D	CI
16-03-15	Pazoo, Inc. Receives Second Six Figure Loan from Two Individual Investors	CI
15-11-09	Pazoo Begins Generating Consulting Based Revenue with the Signing of Operational Advisory Agreement for Denver Colorado Testing Lab	CI
15-07-09	Pazoo, Inc. Signs Distribution Agreement with Pure Grow Systems, LLC	CI

22-10-28	PAZOO, INC. : Entry into a Material Definitive Agreement (form 8-K)	AQ
20-12-07	PAZOO : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	AQ
18-11-14	Pazoo : Posts Conference Call Recording	PR
18-10-31	Pazoo, Inc. : Will Hold Conference Call Thursday November 8, 2018/Pazoo Website Back Up	PR
18-10-11	Pazoo : MA & Associates LLC Accepts First Samples and Begins Testing	PR

Pazoo, Inc. Stock

Stocks

PZOO

US70454Q3048

Healthcare Facilities & Services

Valuation: Pazoo, Inc.

Latest news: Pazoo, Inc.

Press Releases: Pazoo, Inc.

Price Extremes

Managers and Directors: Pazoo, Inc.

Medical & Diagnostic Laboratories

Financials

Company Profile

Quotes

1 month	0		0
Current year	0		0
1 year	0		0
3 years	0		0
5 years	0		0
10 years	0		0.15

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PAZOO, INC.	-.--%	-.--%	-	-	2.69K
NATERA, INC.	+6.07%	+12.32%	+108.81%	+611.28%	49.78B
LABCORP HOLDINGS INC.	-0.55%	+5.14%	+16.90%	+60.04%	26.32B
SONIC HEALTHCARE LIMITED	-1.78%	+1.63%	-12.78%	-37.71%	6.89B
RADNET, INC.	+2.64%	+4.71%	+3.43%	+172.82%	5.96B
DR. LAL PATHLABS LIMITED	+1.53%	+0.42%	+18.03%	+64.80%	3.3B
GENEDX HOLDINGS CORP.	+7.73%	+25.00%	-17.96%	+2,296.12%	2.91B
NEOGENOMICS, INC.	+5.02%	+12.95%	+145.25%	+47.77%	2.43B
FLEURY S.A.	+14.83%	+2.34%	+37.68%	+46.62%	2.26B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	0.00%	+4.06%	-13.81%	-54.60%	1.85B
Average	+3.57%	+4.81%	+31.73%	+356.35%	10.17B
Weighted average by Cap.	+3.60%	+4.72%	+61.10%	+391.23%

	2016	2017
Net sales	30.52K 26.58K 25.15K 22.85K 42.7K 2.92M 42.91K 300K 116K 1.49M 115K 112K 4.75M	-
Net income	-8.8M -7.66M -7.25M -6.59M -12.31M -842M -12.37M -86.36M -33.39M -428M -33.04M -32.31M -1.37B	-3.54M -3.09M -2.92M -2.65M -4.96M -339M -4.98M -34.8M -13.46M -173M -13.32M -13.02M -552M
Net Debt	3.44M 3M 2.84M 2.58M 4.82M 330M 4.84M 33.82M 13.08M 168M 12.94M 12.65M 537M	3.05M 2.65M 2.51M 2.28M 4.26M 292M 4.28M 29.91M 11.57M 148M 11.44M 11.19M 475M